Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD)

NCT04003974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Facioscapulohumeral Muscular Dystrophy (FSHD)

Interventions

DRUG: Losmapimod oral tablet
DRUG: Placebo oral tablet

Sponsor

Fulcrum Therapeutics